Stelara (Ustekinumab) Global Market Report 2025

Global Stelara (Ustekinumab) Market Report 2025

Stelara (Ustekinumab) Global Market Report 2025 ) – By Indication (Plaque Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Other Indications), By Route Of Administration (Subcutaneous Injection, Intravenous Infusion), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Pediatric, Adult, Geriatric) – Market Size, Trends, And Global Forecast 2025-2034

Name: Stelara (Ustekinumab) Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Stelara (Ustekinumab) Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Stelara (Ustekinumab) Global Market Report 2025

Proud Members Of

Stelara (Ustekinumab) Market Definition

Stelara (Ustekinumab) is a monoclonal antibody that targets interleukin-12 (IL-12) and interleukin-23 (IL-23), key proteins involved in inflammatory and autoimmune responses. It is widely used to treat conditions such as moderate-to-severe Plaque Psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.

The main types of indication for stelara (Ustekinumab) include plaque psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and others. Plaque psoriasis is a chronic autoimmune condition characterized by the rapid buildup of skin cells, forming scaly, inflamed patches, often on the scalp, elbows, and knees. It can be administered through both subcutaneous injection and intravenous infusion and is distributed through various channels, including hospital pharmacy, retail pharmacy, and online pharmacy. It is used for pediatric, adult, and geriatric.

Stelara (Ustekinumab) Market Segmentation

The stelara (Ustekinumab)market covered in this report is segmented –

1) By Indication: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Other Indications

2) By Route Of Administration: Subcutaneous Injection, Intravenous Infusion

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

4) By End User: Pediatric, Adult, Geriatric

Stelara (Ustekinumab) Market Size and growth rate 2025 to 2029: Graph

Stelara (Ustekinumab) Market Size 2025 And Growth Rate

The stelara (Ustekinumab) market size has grown strongly in recent years. It will grow from $11,177.34 million in 2024 to $11,850.79 million in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in healthcare spending, growth in specialty drug distribution channels, expansion of clinical trial programs, investment in research and development, increased use of telemedicine facilitating treatment access.

Stelara (Ustekinumab) Market Growth Forecast

The stelara (Ustekinumab) market size is expected to see strong growth in the next few years. It will grow to $14,768.48 million in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to expanding indications for stelara, increasing prevalence of autoimmune diseases, high efficacy in refractory cases compared to alternatives, rising awareness among patients and healthcare providers, growing focus on personalized medicine. Major trends in the forecast period include adoption of biologic therapies, development of advanced drug delivery systems, data-driven healthcare systems, partnerships and licensing agreements between pharmaceutical companies, advances in biologics manufacturing technologies.

Book your 30 minutes free consultation with our research experts

Stelara (Ustekinumab) Market Driver: Rising Psoriasis Prevalence Driving Growth In The Stelara (Ustekinumab) Market

The rise in prevalence of psoriasis patients is expected to propel the growth of the stelara (ustekinumab) market going forward. Psoriasis patients are individuals suffering from a chronic autoimmune disorder that accelerates skin cell turnover, resulting in red, scaly patches. The rise in the prevalence of psoriasis patients can be attributed to several factors, including improved diagnosis, environmental triggers, genetic predisposition, and an aging population. Stelara (ustekinumab) targets and inhibits interleukin-12 and interleukin-23 that helps psoriasis patients by effectively reducing inflammation and plaque formation, leading to improved skin clearance and long-term symptom management, ultimately enhancing their quality of life. For instance, in May 2024, according to a report published by the National Library of Medicine, a US-based medical library, in2022, the prevalence of psoriasis increased to 0.221%, with 6,930 PsA cases reported in a population of 3,133,500. Therefore, the rise in prevalence of psoriasis patients is expected to propel the growth of the stelara (ustekinumab) market.

Global Stelara (Ustekinumab) Market Major Players

Major companies operating in the stelara (ustekinumab) market include Johnson & Johnson

Global Stelara (Ustekinumab) Market Trend: Innovation In The Stelara Biosimilar Market

The key trend in the stelara (ustekinumab) market are developing innovative products, such as biosimilar to stelara, to provide a cost-effective treatment option for patients with chronic inflammatory conditions. Stelara biosimilars are biologically similar medications developed to replicate the therapeutic effects of Stelara (Ustekinumab), targeting IL-12 and IL-23 to treat autoimmune conditions like psoriasis and psoriatic arthritis. For instance, in October 2024, Accord BioPharma Inc., a US-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for IMULDOSA (ustekinumab-srlf), a biosimilar to Johnson & Johnson’s STELARA (ustekinumab). IMULDOSA stands out for its broad indications, offering treatment for adult patients with moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn’s disease, and ulcerative colitis. It is also uniquely indicated for pediatric patients aged 6 years and older with moderate to severe plaque psoriasis and active psoriatic arthritis, making it versatile across age groups. This comprehensive coverage positions IMULDOSA as a valuable option for managing various immune-mediated inflammatory diseases.

Stelara (Ustekinumab) Market Merger And Acquisition: Lotus Pharmaceutical Partners With Favorex Pte Ltd. To Launch Ustekinumab Biosimilar In South Korea

In December 2023, Lotus Pharmaceutical, a Taiwan-based pharmaceutical company, partnered with Favorex Pte Ltd. to bring a biosimilar of ustekinumab to South Korean markets.With this partnership, Lotus Pharmaceutical aims to leverage Favorex Pte Ltd.'s expertise and market presence to introduce a biosimilar of ustekinumab to South Korean markets, addressing the demand for cost-effective biologic therapies and expanding its footprint in the region's pharmaceutical sector. Favorex Pte Ltd. is a Singapore-based pharmaceutical company.

Regional Outlook For The Global Stelara (Ustekinumab) Market

North America was the largest region in the stelara (ustekinumab) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stelara (ustekinumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the stelara (ustekinumab) market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Stelara (Ustekinumab) Market?

The stelara (ustekinumab) market consists of sales of small-molecule drugs, vaccines, immunotherapy products, biosimilars and injectable drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Stelara (Ustekinumab) Industry?

The stelara (ustekinumab) market research report is one of a series of new reports from The Business Research Company that provides stelara (ustekinumab) market statistics, including stelara (ustekinumab) industry global market size, regional shares, competitors with a stelara (ustekinumab) market share, detailed stelara (ustekinumab) market segments, market trends and opportunities, and any further data you may need to thrive in the stelara (ustekinumab) industry. This stelara (ustekinumab) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Stelara (Ustekinumab) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of 5.7% from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Indication: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Other Indications 2) By Route Of Administration: Subcutaneous Injection, Intravenous Infusion 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy 4) By End User: Pediatric, Adult, Geriatric
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Johnson & Johnson
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Stelara (Ustekinumab) Market Characteristics

3. Stelara (Ustekinumab) Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Stelara (Ustekinumab) Market Trends And Strategies

5. Stelara (Ustekinumab) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Stelara (Ustekinumab) Growth Analysis And Strategic Analysis Framework

6.1. Global Stelara (Ustekinumab) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Stelara (Ustekinumab) Market Growth Rate Analysis

6.4. Global Stelara (Ustekinumab) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Stelara (Ustekinumab) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Stelara (Ustekinumab) Total Addressable Market (TAM)

7. Global Stelara (Ustekinumab) Market Pricing Analysis & Forecasts

8. Stelara (Ustekinumab) Market Segmentation

8.1. Global Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plaque Psoriasis

Psoriatic Arthritis

Crohn’s Disease

Ulcerative Colitis

Other Indications

8.2. Global Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Subcutaneous Injection

Intravenous Infusion

8.3. Global Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

8.4. Global Stelara (Ustekinumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric

Adult

Geriatric

9. Global Stelara (Ustekinumab) Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Stelara (Ustekinumab) Market Regional And Country Analysis

10.1. Global Stelara (Ustekinumab) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Stelara (Ustekinumab) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Stelara (Ustekinumab) Market

11.1. Asia-Pacific Stelara (Ustekinumab) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Stelara (Ustekinumab) Market

12.1. China Stelara (Ustekinumab) Market Overview

12.2. China Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Stelara (Ustekinumab) Market

13.1. India Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Stelara (Ustekinumab) Market

14.1. Japan Stelara (Ustekinumab) Market Overview

14.2. Japan Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Stelara (Ustekinumab) Market

15.1. Australia Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Stelara (Ustekinumab) Market

16.1. South Korea Stelara (Ustekinumab) Market Overview

16.2. South Korea Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Stelara (Ustekinumab) Market

17.1. Western Europe Stelara (Ustekinumab) Market Overview

17.2. Western Europe Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Stelara (Ustekinumab) Market

18.1. UK Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Stelara (Ustekinumab) Market

19.1. Germany Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Stelara (Ustekinumab) Market

20.1. France Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stelara (Ustekinumab) Market

21.1. Eastern Europe Stelara (Ustekinumab) Market Overview

21.2. Eastern Europe Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Stelara (Ustekinumab) Market

22.1. North America Stelara (Ustekinumab) Market Overview

22.2. North America Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Stelara (Ustekinumab) Market

23.1. USA Stelara (Ustekinumab) Market Overview

23.2. USA Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Stelara (Ustekinumab) Market

24.1. Canada Stelara (Ustekinumab) Market Overview

24.2. Canada Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Stelara (Ustekinumab) Market

25.1. South America Stelara (Ustekinumab) Market Overview

25.2. South America Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Stelara (Ustekinumab) Market

26.1. Middle East Stelara (Ustekinumab) Market Overview

26.2. Middle East Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Stelara (Ustekinumab) Market

27.1. Africa Stelara (Ustekinumab) Market Overview

27.2. Africa Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Stelara (Ustekinumab) Market Competitive Landscape And Company Profiles

28.1. Stelara (Ustekinumab) Market Competitive Landscape

28.2. Stelara (Ustekinumab) Market Company Profiles

28.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

29. Global Stelara (Ustekinumab) Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Stelara (Ustekinumab) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Stelara (Ustekinumab) Market

32. Recent Developments In The Stelara (Ustekinumab) Market

33. Stelara (Ustekinumab) Market High Potential Countries, Segments and Strategies

33.1 Stelara (Ustekinumab) Market In 2029 - Countries Offering Most New Opportunities

33.2 Stelara (Ustekinumab) Market In 2029 - Segments Offering Most New Opportunities

33.3 Stelara (Ustekinumab) Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Stelara (Ustekinumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Stelara (Ustekinumab) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Stelara (Ustekinumab) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: South Korea, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Western Europe, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: UK, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Germany, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: France, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Eastern Europe, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: North America, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: USA, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Canada, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: South America, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Middle East, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Africa, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Johnson & Johnson Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Stelara (Ustekinumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Stelara (Ustekinumab) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Stelara (Ustekinumab) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: South Korea, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Western Europe, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: UK, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Germany, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: France, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Eastern Europe, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: North America, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: USA, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Canada, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: South America, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Middle East, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Africa, Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Johnson & Johnson Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dtp vaccines market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the human microbiome therapeutics market research report 2022 with industry size, share, segments and market growth

Psoriasis Global Market Report 2025 – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indication (Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis), By Route Of Administration (Oral, Tropical, Injectable ), By Distribution Channel (Hospitals, Retail Pharmacies, E-Commerce ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Radiosurgery And Radiotherapy Robotics Global Market Report 2025 – By Product (X-ray Based, Gamma-ray Based, Proton-beam Based), By Application (External Beam Radiotherapy, Internal Beam Radiotherapy Or Brachytherapy), By End Use (Hospitals, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2025 – By Product Type (Glassia, Aralast NP, Prolastin C, Zemaira And Respreeza), By Route Of Administration (Oral, Injection, Inhalation), By End User (Hospitals, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report 2025 – By Form (Injectables, Oral, Transdermal Patches), By Drug Class (5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class), By Emetogenic Risk (Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)), By Distribution Channel (CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores), By Application (Gynecology, Urology, Gastrointestinal Surgery, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular Immunotherapy Global Market Report 2025 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Convalescent Plasma Therapy Global Market Report 2025 – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment), By End-Users (Hospitals & Clinics, Laboratories & Research institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Drugs For Hormonal Replacement Therapy Global Market Report 2025 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Vitamin D Therapy Global Market Report 2025 – By Administration( Oral, Parenteral), By Purchasing( OTC Drugs, Prescription Drugs), By Age Group( Children, Adults, Senior Adults), By Application( Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Stelara (Ustekinumab) market?

Stelara (Ustekinumab) is a monoclonal antibody that targets interleukin-12 (IL-12) and interleukin-23 (IL-23), key proteins involved in inflammatory and autoimmune responses. It is widely used to treat conditions such as moderate-to-severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. For further insights on the Stelara (Ustekinumab) market, request a sample here

How will the Stelara (Ustekinumab) market drivers and restraints affect the market dynamics? What forces will shape the Stelara (Ustekinumab) industry going forward?

The Stelara (Ustekinumab) market major growth driver - Rising Psoriasis Prevalence Driving Growth In The Stelara (Ustekinumab) Market. For further insights on the Stelara (Ustekinumab) market, request a sample here

What is the forecast market size or the forecast market value of the Stelara (Ustekinumab) market?

The Stelara (Ustekinumab) market size has grown strongly in recent years. The stelara (ustekinumab) market size has grown strongly in recent years. It will grow from $11,177.34 million in 2024 to $11,850.79 million in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in healthcare spending, growth in specialty drug distribution channels, expansion of clinical trial programs, investment in research and development, increased use of telemedicine facilitating treatment access. The stelara (ustekinumab) market size is expected to see strong growth in the next few years. It will grow to $14,768.48 million in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to expanding indications for stelara, increasing prevalence of autoimmune diseases, high efficacy in refractory cases compared to alternatives, rising awareness among patients and healthcare providers, growing focus on personalized medicine. Major trends in the forecast period include adoption of biologic therapies, development of advanced drug delivery systems, data-driven healthcare systems, partnerships and licensing agreements between pharmaceutical companies, advances in biologics manufacturing technologies. For further insights on the Stelara (Ustekinumab) market, request a sample here

How is the Stelara (Ustekinumab) market segmented?

The stelara (ustekinumab)market covered in this report is segmented –
1) By Indication: Plaque Psoriasis; Psoriatic Arthritis; Crohn’s Disease; Ulcerative Colitis; Other Indications
2) By Route Of Administration: Subcutaneous Injection; Intravenous Infusion
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
4) By End User: Pediatric; Adult; Geriatric For further insights on the Stelara (Ustekinumab) market, request a sample here

Which region has the largest share of the Stelara (Ustekinumab) market? What are the other regions covered in the report?

Who are the major players in the Stelara (Ustekinumab) market?

Major companies operating in the stelara (ustekinumab) market include Johnson & Johnson . For further insights on the Stelara (Ustekinumab) market, request a sample here.

What are the key trends in the Stelara (Ustekinumab) market?

Major trends in the Stelara (Ustekinumab) market include Innovation In The Stelara Biosimilar Market. For further insights on the Stelara (Ustekinumab) market, request a sample here.

What are the major opportunities in the Stelara (Ustekinumab) market? What are the strategies for the Stelara (Ustekinumab) market?

For detailed insights on the major opportunities and strategies in the Stelara (Ustekinumab) market, request a sample here.

How does the Stelara (Ustekinumab) market relate to the overall economy and other similar markets?

For detailed insights on Stelara (Ustekinumab)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Stelara (Ustekinumab) industry?

For detailed insights on the mergers and acquisitions in the Stelara (Ustekinumab) industry, request a sample here.

What are the key dynamics influencing the Stelara (Ustekinumab) market growth? SWOT analysis of the Stelara (Ustekinumab) market.

For detailed insights on the key dynamics influencing the Stelara (Ustekinumab) market growth and SWOT analysis of the Stelara (Ustekinumab) industry, request a sample here.